Delivery Order SPE2DB22D2006-SPE2DB26FV5VN
- Not listed
- The Defense Logistics Agency awarded a $2,011.38 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. The award, issued on September 2, 2025, is a firm fixed price contract with an ultimate completion date of September 3, 2025. This delivery order carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $7,581.32 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.11 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 18, 2025. This competitive, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,473.86 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader federal pharmaceutical supply portfolio supporting...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.17 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a firm fixed price and an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract was issued on September 8, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,763.76 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $1,610.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child contract...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB26FV5VNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,161.71 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of medications, medical supplies, and healthcare commodities to support military healthcare systems and other federal government customers. The contract vehicle reflects DLA's strategy to maintain flexible, competitively awarded agreements with qualified pharmaceutical distributors to meet ongoing defense and federal healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/24/25 |